PAX7 expression was detected at lower levels in six out of 11 cases of RMS with PAX3/7-FKHR fusion genes, whereas 15 out of 19 ARMS and ERMS cases lacking the fusion genes expressed PAX7, generally at much higher levels (Table 2 and Figure 1C). This evidence concerns the gene PAX3 and alveolar rhabdomyosarcoma.